Venclexta With a Hypomethylating Agent Shows Promise for Patients with Acute Myeloid Leukemia

FDA Committee Recommends Continuing Accelerated Approval Status of Tecentriq in Certain Patients with Metastatic Triple-Negative Breast Cancer

When Oncologists Retire, Their Patients Must Learn to Embrace Change

A Prostate Cancer Researcher’s Unique Perspective as A Cancer Survivor